The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of tivozanib in patients with metastatic and nonresectable soft-tissue sarcomas.
Lauren Elizabeth Nye
No relevant relationships to disclose
Ariel Polish
No relevant relationships to disclose
Susan E. Abbinanti
No relevant relationships to disclose
Claudia Roxana Vintilescu
No relevant relationships to disclose
Alfred Rademaker
No relevant relationships to disclose
Catherine Humphreys
No relevant relationships to disclose
Rasima Cehic
No relevant relationships to disclose
Thomas McFarland
No relevant relationships to disclose
Mohammed M. Milhem
No relevant relationships to disclose
Keith M. Skubitz
No relevant relationships to disclose
Brian Andrew Van Tine
No relevant relationships to disclose
Scott H. Okuno
No relevant relationships to disclose
Mark Agulnik
No relevant relationships to disclose